Unlocking the Potential of Clozapine in Treatment-Resistant Schizophre

Introduction

Treatment-Resistant Schizophrenia (TRS) is a complex and challenging clinical condition characterized by an inadequate response to at least two different antipsychotic treatments given at appropriate doses and durations.1,2

Continue Reading